Mechanisms of Bone Impairment in Sickle Bone Disease

Area of Science:

• Hematology
• Orthopedics
• Genetics
• Endocrinology

Background:

• Sickle bone disease (SBD) is a debilitating complication of sickle cell disease (SCD), a global genetic disorder.
• The exact mechanisms driving SBD, particularly in children, remain incompletely understood.
• Hypothesized causes include bone marrow hyperplasia, ischemic damage, hypoxia, and altered bone metabolism.

Purpose of the Study:

• To review the pathogenesis of SBD in sickle cell disease (SCD).
• To update knowledge on biochemical, instrumental, and biological markers of bone metabolism in SBD.
• To evaluate growth development and endocrine complications in SCD patients.

Main Methods:

• Literature review focusing on the pathogenesis of sickle bone disease (SBD).
• Analysis of studies on biochemical, instrumental, and biological markers of bone metabolism.
• Evaluation of growth and endocrine data in sickle cell disease (SCD) subjects.

Main Results:

• Pathogenesis involves vaso-occlusive crisis (VOC), hypoxia, erythropoietin activation, hemolysis, and iron overload.
• Vitamin D deficiency exacerbates bone loss, leading to low bone mineral density and increased fracture risk.
• Imbalances in osteoblast and osteoclast activity, delayed puberty, and low peak bone mass contribute to bone impairment.

Conclusions:

• Sickle bone disease (SBD) results from a multifactorial interplay of vascular, cellular, and metabolic factors in sickle cell disease (SCD).
• Further research into bone metabolism markers and endocrine complications is essential for effective SBD management.
• Understanding these mechanisms can improve bone health outcomes and reduce fracture incidence in SCD patients.